bad breath semaglutide The Ugly Side of Weight-Loss Drugs: Rotten Breath, Damaged Teeth, and Dry Mouth Halitosis and the Menstrual Cycle
Description
A GLP-1/glucagon (GCG)/CCK2 receptors tri-agonist provides new therapy for obesity and diabetes
Referral to neurology, neuropsychology, sleep medicine, endocrinology, or psychiatry may be appropriate for persistent, unexplained cognitive symptoms that do not respond to initial interventions
/shethepeople/media/media_files/2025/06/06/tfyB92i0wp2SyzWgpIx4.png)
Under U.S
VK2735: Phase 2 trial results for oral VK2735 are expected in the second half of 2025
